Keywords: abbott, humira, maintains, 1-year, remission, crohn, health
Abbott's Humira maintains 1-year remission in Crohn's
Article | 29 May 2006
US health care major Abbott Laboratories reported study data showing that patients with moderate to severely-active Crohn's disease treated with ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
